Skip to main content

Oxitec Mosquito Trial

Oxitec 2nd Generation Mosquito Trial

The release phase of the FKMCD-Oxitec Mosquito Trial came to an end Summer, 2024.  It is now up to the U..S. Environmental Protection Agency to determine if the Oxitec mosquito will be available for use as a registered mosquito control product in the United States.

Box labeled "Oxitec" on a sandy beach with palm trees and greenery in the background.
The Oxitec product uses genetically altered, male Aedes aegypti mosquitoes as a means to  reduce the population of that species. The Oxitec mosquitoes have been proven to only father live male offspring which carry the same trait. 

To Read more about the history of the project and current status, please visit the project website:

keysmosquitoproject.com

To review Oxitec’s Experimental Use Permit application with the Environmental Protection Agency for the proposed trial, please open the application.

To submit a public comment to the Environmental Protection Agency on Oxitec’s Experimental Use Permit application, please click on the comment link.

For questions and Answers regarding the Proposed Oxitec 2nd Generation Mosquito trial, please visit the Oxitec website.

 

Approval Process Updates 

Latest Updates in the Approval Process

August 18, 2020 – The Florida Keys Mosquito Control Board votes four to one in favor of proceeding with the Oxitec trial in the year 2021. Read the FKMCD news release on the vote HERE. 

July 21, 2020 – Florida Keys Mosquito Control District Board schedules vote on Oxitec Proposal.

July 14, 2020 – Florida Keys Mosquito Control District Board District and Oxitec host Public Educational ‘Webinar’ to answer questions about the proposed Oxitec Project.

June 23, 2020 – Florida Keys Mosquito Control District Board holds Public Information Workshop to gather information on the proposed Oxitec project.

View the Oxitec Presentation. 

June 16, 2020 – Florida Department of Agriculture and Consumer Services (FDACS) announces approval to Oxitec for field test the use of genetically engineered Aedes aegypti mosquitoes as a way to reduce mosquito populations to protect public health from mosquito-borne illnesses.

View the Oxitec News Release. 

May 1, 2020 – U.S. Environmental Protection Agency announces approval to Oxitec to field test the use of genetically engineered Aedes aegypti mosquitoes as a way to reduce mosquito populations to protect public health from mosquito-borne illnesses.

View EPA Response to Comments on the Experimental Use Application.  

October 11, 2019 – 30-day Public Comment period on the Experimental Use Permit ends.

September 11, 2019 – 30-day Public Comment period on the Experimental Use Permit application opened today.  It will close on October 11, 2019, at 11:59 p.m.

September 11, 2019 – The Environmental Protection Agency (EPA) accepts Oxitec’s application for an Experimental Use Permit for its 2nd Generation Aedes aegypti mosquito.

Information on Previous Oxitec Application 

1st Generation (OX513A) Mosquito

A project using the OX513A mosquito is no longer being pursued.

OX513A FAQs

A project using the OX513A mosquito is no longer being pursued.

OX513A Other Documents

A project using the OX513A mosquito is no longer being pursued.

To review Oxitec publications and information that was presented to Commissioners at the November 19, 2016, Board Meeting, please go to the document.

To review the FDA’s final Environmental Assessment on the Proposed Oxitec OX513A Mosquito Project by visiting this link.

December 4, 2014 Town Hall Meeting

March 15, 2012 Town Hall Meeting